Nasogastric Tube Market Size is expected to observe a healthy CAGR between 2022 and 2028. Manufactured from flexible rubber or plastic, nasogastric tubes are commonly used for the delivery of liquid nutrition directly to the stomach when a person cannot eat enough for meeting his/her body requirements. Prominent factors driving the usage of NG tubes comprise the administration of medication and nutrients, addition of contrast to the stomach for X-rays, removal of air or liquids from the stomach, and protection of the bowel post-surgery or during bowel rest.
On the basis of type, the Levin catheter segment is anticipated to account for a considerable share in the nasogastric tube market through 2028. This rise is mainly credited to the increasing adoption of Levin tubes that have a single lumen and holes at the tip. These tubes are used for washing out the stomach (lavage), reducing pressure in the stomach (decompression), or feeding in hospitals, clinics, and healthcare institutions on an extensive scale.
Based on end-use, the hospitals segment is estimated to foresee lucrative expansion up to 2028 impelled by the growing occurrence of ingestion and gastrointestinal problems among the aging population. When such cases occur, essential nutrients are supplemented via the enteral route, which positively influences the demand for nasogastric tube feeding. The segmental expansion is further being propelled by the expanding geriatric pool and the escalating incidence of chronic diseases across various regions.
Considering the regional landscape, North America nasogastric tube market is slated to register commendable growth during the forecast period owing to the formulation of various regulatory guidelines. For instance, in June 2021, the U.S. FDA issued recommendations for testing the suitability of oral drug products for enteral feeding tube administration. Such developments propel the need for efficient nasogastric tubes given that these could be required for the maintenance of adequate nutrition for various reasons such as swallowing difficulty, cancer, severe genetic or acquired neurological impairment, and other diseases.
Major players in the nasogastric tube market comprise Rontis Medical, Degania Medical, Cardinal Health, C. R. Bard Medical (Becton, Dickinson and Company). A number of nasogastric tube manufacturers are focused on the adoption of strategic initiatives such as acquisitions, mergers, product developments, collaborations, and partnerships for the consolidation of their position in the market.
For instance, Cardinal Health’s Salem Sump Tubes enables safer intermittent and continuous gastric suctioning. The company additionally claims that the large lumen of the tube allows decompression, easy suction of gastric contents, medication delivery, and irrigation.
The COVID-19 pandemic has led to an increase in studies for enhancing the efficiency of enteral feeding for ICU (Intensive Care Units) patients. This is because the SARS-CoV-2 population might be at a greater risk due to the requirement for emergence delirium, long duration of invasive ventilation, and the need for proning.
According to one such study, the usage of nasogastric tube bridle kits decreases the count of NGT insertions that are required by patients and also lowers the number of chest radiographs required by them. Such findings are predicted to the development of efficient nasogastric tube feeding equipment through the pandemic period.
Market, by Type
Market, by Patient
Market, by End-use
The above information is provided for the following regions and countries: